Company: INTS
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001567264-25-000010
Chunk: 8

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 16
Chunk 8
---
ITEM 16. FORM 10-K SUMMARY

None

113

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

Intensity Therapeutics, Inc.Date: March 13, 2025By:/s/ Lewis H. BenderLewis H. BenderPresident, Chief Executive Officer and Chairman

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.

NameTitleDate   /s/ Lewis H. BenderPresident, Chief Executive Officer and ChairmanMarch 13, 2025Lewis H. Bender(principal executive officer) /s/ Joseph TalamoChief Financial OfficerMarch 13, 2025Joseph Talamo(principal financial officer) /s/ John WesolowskiPrincipal Accounting Officer and ControllerMarch 13, 2025John Wesolowski(principal accounting officer) /s/ Daniel DonovanDirectorMarch 13, 2025Daniel Donovan  /s/ Dr. Emer LeahyDirectorMarch 13, 2025Dr. Emer Leahy     /s/ Dr. Mark A. GoldbergDirectorMarch 13, 2025Dr. Mark A. Goldberg  /s/ Thomas I. H. DubinDirectorMarch 13, 2025Thomas I. H. Dubin

114

Table of Contents

INTENSITY THERAPEUTICS, INC.

INDEX TO FINANCIAL STATEMENTS

PageReport of Independent Registered Public Accounting Firm (PCAOB #274)Financial StatementsBalance sheets as of December 31, 2024 and 2023F-3Statements of operations for the years ended December 31, 2024 and 2023F-4Statements of changes in redeemable convertible preferred stock and stockholders’ equity (deficiency) for the years ended December 31, 2024 and 2023F-5Statements of cash flows for the years ended December 31, 2024 and 2023F-6Notes to December 31, 2024 and 2023 financial statementsF-7

F-1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Stockholders of